Wikisage, the free encyclopedia of the second generation, is digital heritage
Mepolizumab: Difference between revisions
Jump to navigation
Jump to search
(→Links) |
(→Links) |
||
| Line 5: | Line 5: | ||
[https://karmel.miraheze.org/wiki/Mepolizumab karmel(miraheze):Mepolizumab] | [https://karmel.miraheze.org/wiki/Mepolizumab karmel(miraheze):Mepolizumab] | ||
{{Wikadata|Q3306175}} | |||
{{refs}} | {{refs}} | ||
Revision as of 16:05, 23 January 2020
Mepolizumab is a humanized monoclonal antibody to interleukin-5 (IL-5) which leads to a decrease in production and maturation of eosinophils and results in a reduction in allergic symptoms of asthma and hypereosinophilic síndromes [1]
Links
| References: |